Stage 4S Neuroblastoma: What Are the Outcomes? A Systematic Review of Published Studies.
Arimatias RaitioMichael J RiceDhanya MullasseryPaul D LostyPublished in: European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie (2020)
There is a significant mortality observed in stage 4S/MS neuroblastoma infants with a dismal outcome observed in those patients with MYCN amplification and 1p/11q deletion. Those patients suitably amenable for conservative management or surgery to excise the primary tumor carry the best prognosis.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- minimally invasive
- chronic kidney disease
- prognostic factors
- mass spectrometry
- peritoneal dialysis
- ms ms
- cardiovascular events
- risk factors
- type diabetes
- coronary artery bypass
- randomized controlled trial
- metabolic syndrome
- cardiovascular disease
- patient reported outcomes
- insulin resistance